The drug risks of cilostazol: A pharmacovigilance study of FDA Adverse Event Reporting System database

• Lufeng Peng ,

  Contributed equally to this work with: Lufeng Peng, Xueli Li

  Roles Conceptualization, Data curation, Writing – original draft, Writing – review & editing

  Affiliation Qilu Hospital of Shandong University, Jinan, Shandong Province, China

  ⨯
• Xueli Li ,

  Contributed equally to this work with: Lufeng Peng, Xueli Li

  Roles Data curation, Writing – original draft, Writing – review & editing

  Affiliation Dongying People’s Hospital (Dongying Hospital of Shandong Provincial Hospital Group), Dongying, Shandong Province, China

  ⨯
• Junhai Li,

  Roles Data curation, Formal analysis, Methodology

  Affiliation Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China

  ⨯
• Shibin Liu ,

  Roles Supervision, Writing – review & editing

  * E-mail: liushibin202408@163.com (SL); lianggang202408@163.com (GL)

  ¶‡ These authors also contributed equally to this work.

  Affiliation Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China

  ⨯
• Gang Liang

  Roles Supervision, Writing – review & editing

  * E-mail: liushibin202408@163.com (SL); lianggang202408@163.com (GL)

  ¶‡ These authors also contributed equally to this work.

  Affiliation Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province, China

  https://orcid.org/0009-0004-5332-6327

  ⨯